Indication

Hyperkeratosis

Hyperkeratosis refers to the abnormal thickening of the stratum corneum, the outermost layer of the epidermis, typically resulting from excess production of keratin or retention of corneocytes. Read more about Hyperkeratosis

117 drugs 45 manufacturers

Advertisement

Drugs that treat it

Common Hyperkeratosis therapies.

Showing 46–54 of 117 drugs

Filter & compare in the drug finder →Opens the drug finder with Hyperkeratosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hyperkeratosis.

Hyperkeratosis refers to the abnormal thickening of the stratum corneum, the outermost layer of the epidermis, typically resulting from excess production of keratin or retention of corneocytes.

It primarily affects the integumentary system across diverse patient populations and can manifest as localized or generalized rough, scaly, thickened plaques, calluses, or papules.

Pathophysiologically, it arises as a protective physiologic response to chronic friction, or secondary to underlying inflammatory dermatoses, genetic disorders of cornification, or premalignant alterations.

Histologically, it is broadly subclassified into orthokeratotic hyperkeratosis, where keratinocyte maturation is preserved without retained nuclei, and parakeratotic hyperkeratosis, marked by retained cellular nuclei reflecting altered epidermal transit.

Personalize your experience

Follow Hyperkeratosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it